239 related articles for article (PubMed ID: 29260666)
1. Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014.
Bonnar PE; Cunningham NP; Boggild AK; Walsh NM; Sharma R; Davis IRC
Emerg Infect Dis; 2018 Jan; 24(1):165-166. PubMed ID: 29260666
[TBL] [Abstract][Full Text] [Related]
2. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
3. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
4. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
5. Autochthonous borderline tuberculoid leprosy in a man from Florida.
Villada G; Zarei M; Romagosa R; Forgione P; Fabbrocini G; Romanelli P
Lepr Rev; 2016 Mar; 87(1):101-3. PubMed ID: 27255063
[TBL] [Abstract][Full Text] [Related]
6. Single-dose treatment for paucibacillary leprosy; field implications.
Revankar CR; Pai VV; Samy MS; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
[No Abstract] [Full Text] [Related]
7. Three indigenous cases of leprosy in the Mississippi delta.
Abide JM; Webb RM; Jones HL; Young L
South Med J; 2008 Jun; 101(6):635-8. PubMed ID: 18475242
[TBL] [Abstract][Full Text] [Related]
8. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
9. A case of leprosy in central Florida.
Anderson KL; Minni JP; Nowak MA; Karai LJ; Sanik E
Cutis; 2017 Nov; 100(5):327-329. PubMed ID: 29232423
[TBL] [Abstract][Full Text] [Related]
10. Single dose multidrug therapy for single lesion paucibacillry leprosy.
Salafia A
Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
[No Abstract] [Full Text] [Related]
11. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
Kumarasinghe SP; Kumarasinghe MP
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
[No Abstract] [Full Text] [Related]
12. Case Report of Leprosy in Central Florida, USA, 2022.
Bhukhan A; Dunn C; Nathoo R
Emerg Infect Dis; 2023 Aug; 29(8):1698-1700. PubMed ID: 37486691
[TBL] [Abstract][Full Text] [Related]
13. Zoonotic Leprosy in the Southeastern United States.
Sharma R; Singh P; Loughry WJ; Lockhart JM; Inman WB; Duthie MS; Pena MT; Marcos LA; Scollard DM; Cole ST; Truman RW
Emerg Infect Dis; 2015 Dec; 21(12):2127-34. PubMed ID: 26583204
[TBL] [Abstract][Full Text] [Related]
14. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic prospects for paucibacillary leprosy.
Katoch K
Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
[No Abstract] [Full Text] [Related]
16. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
17. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leprosy in Central Florida man with significant armadillo exposure.
Logas CM; Holloway KB
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31256049
[TBL] [Abstract][Full Text] [Related]
19. Single dose ROM therapy in Goa.
Shukla P; Miranda MS; Prabhudesai R; Rege VL
Indian J Lepr; 2002; 74(2):169-72. PubMed ID: 12708738
[No Abstract] [Full Text] [Related]
20. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
